BIOTECHNOLOGY AND LIFE SCIENCES products beginning with : A
6051 to 6100 of 9097 results Page: 
120 121 [122] 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 
120 121 [122] 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140
Anti-ITGAL (Odulimomab)-MC-MMAF ADC (1 supplier)
Anti-ITGAL (Odulimomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGAL (Odulimomab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGAL (Odulimomab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGAL (Odulimomab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGAL (Odulimomab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV (Abituzumab)-MC-MMAF ADC (1 supplier)
Anti-ITGAV (Abituzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGAV (Abituzumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGAV (Abituzumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGAV (Abituzumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGAV (Abituzumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV (clone MF-T)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV (Intetumumab)-MC-MMAF ADC (1 supplier)
Anti-ITGAV (Intetumumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGAV (Intetumumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGAV (Intetumumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGAV (Intetumumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGAV (Intetumumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV Neutralizing Antibody (V3S-0622-YC4858) (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-MC-MMAF ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV-DM4 ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-MC-MMAF ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-MC-MMAF ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-MC-MMAF ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITIH4-Mc-MMAF ADC (1 supplier)
Anti-ITIH4-Mc-VC-PABC-MMAE ADC (1 supplier)
Anti-ITIH4-MCC-DM1 ADC (1 supplier)
Anti-ITIH4-SPP-DM1 ADC (1 supplier)
Anti-Japanese Encephalitis Monoclonal Antibody (2 suppliers)
Anti-ITGAL (Odulimomab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGAL (Odulimomab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGAL (Odulimomab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGAL (Odulimomab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGAL (Odulimomab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV (Abituzumab)-MC-MMAF ADC (1 supplier)
Anti-ITGAV (Abituzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGAV (Abituzumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGAV (Abituzumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGAV (Abituzumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGAV (Abituzumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV (clone MF-T)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV (Intetumumab)-MC-MMAF ADC (1 supplier)
Anti-ITGAV (Intetumumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGAV (Intetumumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGAV (Intetumumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGAV (Intetumumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGAV (Intetumumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV Neutralizing Antibody (V3S-0622-YC4858) (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-MC-MMAF ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGAV+ITGB3 (Etaracizumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGAV-DM4 ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-MC-MMAF ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGB2 (Erlizumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-MC-MMAF ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGB2 (Rovelizumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-MC-MMAF ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-MC-Vc-PAB-MMAE ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-MC-Vc-PAB-SN38 ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-SMCC-DM1 ADC (1 supplier)
Anti-ITGB3 (Tadocizumab)-SPDB-DM4 ADC (1 supplier)
Anti-ITIH4-Mc-MMAF ADC (1 supplier)
Anti-ITIH4-Mc-VC-PABC-MMAE ADC (1 supplier)
Anti-ITIH4-MCC-DM1 ADC (1 supplier)
Anti-ITIH4-SPP-DM1 ADC (1 supplier)
Anti-Japanese Encephalitis Monoclonal Antibody (2 suppliers)
